Akebia Therapeutics
AKBA
#7494
Rank
โ‚น36.71 B
Marketcap
โ‚น138.35
Share price
-3.14%
Change (1 day)
-19.12%
Change (1 year)

Akebia Therapeutics (AKBA) Fails to deliver data

Key failure to deliver metrics for Akebia Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Akebia Therapeutics (AKBA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Akebia Therapeutics (AKBA) - since 2014

Volume in USD (price x number of shares), data since 2014

Akebia Therapeutics (AKBA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚น4.09 M-14.97%
2024โ‚น4.81 M79.6%
2023โ‚น2.68 M-41.28%
2022โ‚น4.56 M8.92%
2021โ‚น4.19 M-18.58%
2020โ‚น5.15 M43.43%
2019โ‚น3.59 M-62.25%
2018โ‚น9.51 M238.71%
2017โ‚น2.8 M-25.14%
2016โ‚น3.75 M92.2%
2015โ‚น1.95 M-88.22%
2014โ‚น16.56 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Amgen
AMGN
โ‚น5.75 Mโ‚น0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น18.77 Mโ‚น0.12 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
โ‚น54.31 Mโ‚น94.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
N/Aโ‚น0.36 M๐Ÿ‡บ๐Ÿ‡ธ USA